EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The human retroviral-like aspartic protease 1 (ASPRV1): From in vitro studies to clinical correlations

János András Mótyán, József Tőzsér

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von János András Mótyán und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: motyan.janos@me…. Hauptthemen laut MEDLINE: Filaggrin Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Academy of Sciences, National Research Development and Innovation Office, University of Debrecen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human retroviral-like aspartic protease 1 (ASPRV1) is a retroviral-like protein that was first identified in the skin due to its expression in the stratum granulosum layer of the epidermis. Accordingly, it is also referred to as skin-specific aspartic protease. Similar to the retroviral polyproteins, the full-length ASPRV1 also undergoes self-proteolysis, the processing of the precursor is necessary for the autoactivation of the protease domain. ASPRV1's functions are well-established at the level of the skin: it is part of the epidermal proteolytic network and has a significant contribution to skin moisturization via the limited proteolysis of filaggrin; it is only natural protein substrate identified so far. Filaggrin and ASPRV1 are also specific for mammalians, these proteins provide unique features for the skins of these species, and the importance of filaggrin processing in hydration is proved by the fact that some ASPRV1 mutations are associated with skin diseases such as ichthyosis. ASPRV1 was also found to be expressed in macrophage-like neutrophil cells, indicating that its functions are not limited to the skin. In addition, differential expression of ASPRV1 was detected in many diseases, with yet unknown significance. The currently known enzymatic characteristics-that had been revealed mainly by in vitro studies-and correlations with pathogenic phenotypes imply potentially important functions in multiple cell types, which makes the protein a promising target of functional studies. In this review we describe the currently available knowledge and future perspective in regard to ASPRV1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Filaggrin ProteinsHumansIntermediate Filament ProteinsSkinAnimalsAspartic Acid ProteasesSkin DiseasesProteolysis

Stichwörter der Autor:innen

ASPRV1SASPaseaspartic proteaseproteaseproteolysisskinviral protein

Substanzen

Filaggrin ProteinsFLG protein, humanIntermediate Filament ProteinsAspartic Acid Proteases

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address: motyan.janos@med.unideb.hu.
  • Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Förderung

  • Hungarian Academy of Sciences
  • National Research Development and Innovation Office
  • University of Debrecen

Zitieren

APA

Mótyán, J. A., & Tőzsér, J. (2024). The human retroviral-like aspartic protease 1 (ASPRV1): From in vitro studies to clinical correlations. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107634

Vancouver

Mótyán JA, Tőzsér J. The human retroviral-like aspartic protease 1 (ASPRV1): From in vitro studies to clinical correlations. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107634

BibTeX
@article{Mtyn2024,
  author = {Mótyán, János András and Tőzsér, József},
  title = {The human retroviral-like aspartic protease 1 (ASPRV1): From in vitro studies to clinical correlations},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107634}
}
Kostenlos starten →